QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by National Institute on Drug Abuse (NIDA).
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT01065493
First received: February 8, 2010
Last updated: NA
Last verified: February 2010
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
QuitAdvisorMD: A point-of-care tool for brief smoking cessation interventions Under a Phase II SBIR grant supported by NIH/NIDA, we are developing QUITAdvisorMD: a point-of-care, patient-centered resource for counseling patients who smoke or use tobacco products. It is based on the principles of Motivational Interviewing, a non-confrontational and very effective method for intervening and treating these patients; the 5 A's of behavioral interventions; and the Transtheoretical Model of Change. Through a point and click interface, the tool uses a series of interview questions designed to motivate patients to stop smoking by first assessing their stage of change and then offering effective stage-based interventions and interview techniques. The tool also offers stage-tailored patient information, a clinician educational reference, and the ability to communicate support information patients via email and/or text message.
| Condition | Intervention | Phase |
|---|---|---|
|
Smoking Tobacco Use Disorder |
Other: QuitAdvisorMD Software Algorithm Behavioral: Standard Smoking Cessation Counseling |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions |
Resource links provided by NLM:
Further study details as provided by National Institute on Drug Abuse (NIDA):
Primary Outcome Measures:
- The goal of the evaluation is to assess the ability of QuitAdvisorMD to influence smoking cessation as measured by the primary outcome of the increase in physician initiated smoking cessation counseling. [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Secondary outcomes will include, 1) the increase in ability of clinicians to provide appropriate stage-based smoking cessation assistance, and 2) the increase in patient quit attempts. [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 100 |
| Study Start Date: | April 2010 |
| Estimated Study Completion Date: | April 2011 |
| Estimated Primary Completion Date: | April 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Software Assisted Lifestyle Counseling |
Other: QuitAdvisorMD Software Algorithm
QuitAdvisorMD, a set of brief clinical assessments, counseling scripts and intervention instruments for smoking cessation in primary care settings
|
|
Active Comparator: Lifestyle Counseling
Status quo smoking cessation counseling.
|
Behavioral: Standard Smoking Cessation Counseling
Standard Smoking Cessation Counseling
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- any physician providing care for members of Southern Health through primary care and have access to a point-of-care computing device (Smartphone, desktop PC, etc) during patient visits.
Exclusion Criteria:
- Lack of appropriate computing device
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01065493
Contacts
| Contact: Sandra Pelletier, PhD | 434-924-5509 | SLP6U@hscmail.mcc.virginia.edu |
| Contact: Scott Strayer, MD, MPH | 434-982-3294 | SMS6U@hscmail.mcc.virginia.edu |
Locations
| United States, Virginia | |
| University of Virginia Health System | Not yet recruiting |
| Charlottesville, Virginia, United States, 22908 | |
| Contact: Sandra Pelletier, PhD 434-924-5509 SLP6U@hscmail.mcc.virginia.edu | |
| Contact: Scott Strayer, MD, MPH 434-982-3294 SMS6U@hscmail.mcc.virginia.edu | |
| Principal Investigator: Scott Strayer, MD, MPH | |
Sponsors and Collaborators
Investigators
| Principal Investigator: | Gerge Reynolds, BA | Silverchair, Inc |
| Principal Investigator: | Scott Strayer, MD | University of Virginia Health System |
More Information
No publications provided
| Responsible Party: | George L. Reynolds, VP & Director of Healt Information Research, Silverchair, Inc |
| ClinicalTrials.gov Identifier: | NCT01065493 History of Changes |
| Other Study ID Numbers: | R44 DA026682 |
| Study First Received: | February 8, 2010 |
| Last Updated: | February 8, 2010 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Smoking Tobacco Use Disorder Habits Substance-Related Disorders Mental Disorders |
ClinicalTrials.gov processed this record on October 17, 2012
